watching for [5%:1,500/mm 3 for 3 consecutive days or a maximum of 42 days. If ANC >20,000/mm 3 , interrupt treatment or reduce the dose by 50%. If a second cycle of chemotherapy is necessary, administer ~4 days after the completion of chemotherapy if the bone marrow is hypoplastic with] Drug Status Rx Availability Prescription only C Pregnancy Category Risk cannot be ruled out N/A CSA Schedule Not a controlled drug Approval History Drug history at FDA Sargramostim Rating No Reviews - Be the first! No Reviews - Be the first! Not Rated - Be the first! Drug Class Colony stimulating factors Related Drugs colony stimulating factors Neulasta , Neupogen , filgrastim , Zarxio , Granix , pegfilgrastim Neutropenia Associated with Chemotherapy Neulasta , Neupogen , filgrastim , Zarxio , Granix , pegfilgrastim , More... Aplastic Anemia Promacta , eltrombopag , Leukine , Atgam , lymphocyte immune globulin, anti-thy (equine) , More... Bone Marrow Transplantation fluconazole , Diflucan , cisplatin , Neupogen , filgrastim , Zarxio , More... 2 more conditions... the fact
lifelike Sargramostim because of
EmoticonEmoticon